NN Investment Partners Holdings’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-2,800
Closed -$283K 791
2020
Q3
$283K Buy
+2,800
New +$307K ﹤0.01% 664
2019
Q1
Sell
-42,234
Closed -$4.6M 792
2018
Q4
$4.6M Sell
42,234
-54,913
-57% -$6.37M 0.04% 295
2018
Q3
$12.4M Buy
97,147
+5,840
+6% +$722K 0.09% 187
2018
Q2
$10.3M Sell
91,307
-5,404
-6% -$594K 0.08% 203
2018
Q1
$10.9M Sell
96,711
-39,268
-29% -$4.99M 0.08% 205
2017
Q4
$20.1M Buy
135,979
+126,522
+1,338% +$16.1M 0.14% 141
2017
Q3
$1.17M Buy
9,457
+4,853
+105% +$620K 0.01% 551
2017
Q2
$597K Sell
4,604
-2,423
-34% -$302K 0.01% 552
2017
Q1
$952K Sell
7,027
-108,212
-94% -$16.4M 0.01% 447
2016
Q4
$16.5M Sell
115,239
-16,458
-12% -$2.1M 0.16% 146
2016
Q3
$15.6M Buy
131,697
+33,640
+34% +$4.04M 0.15% 141
2016
Q2
$10.4M Buy
98,057
+11,888
+14% +$1.33M 0.1% 166
2016
Q1
$9.6M Buy
+86,169
New +$10.9M 0.09% 178

Other funds holding UTHR

NN Investment Partners Holdings's UTHR Position: Q4 2020 in Review

NN Investment Partners Holdings sold out of United Therapeutics (UTHR) in Q4 2020, closing a stake of 2,800 shares — an estimated $283K sold.

NN Investment Partners Holdings first reported a position in UTHR in Q1 2016 and held it in 13 quarters. The position peaked at $20.1M in Q4 2017. 356 funds tracked by Wall St. Rank hold UTHR as of Q4 2020.

  • NN Investment Partners Holdings reported no remaining United Therapeutics position as of Q4 2020 after selling out during the quarter.
  • NN Investment Partners Holdings sold 2,800 United Therapeutics shares in Q4 2020, an estimated $283K.
  • NN Investment Partners Holdings first reported a position in United Therapeutics in Q1 2016 and held it in 13 quarters.
  • NN Investment Partners Holdings's United Therapeutics position peaked at $20.1M in Q4 2017.
  • 356 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2020.

Based on NN Investment Partners Holdings's 13F filing for Q4 2020, filed 1 Feb 2021.